U.S. Canine Separation Anxiety Market Climbs from USD 27.7
Press release
U.S. Canine Separation Anxiety Market Climbs from USD 27.7 billion to USD 49.4 billion by 2036 at 5.4% CAGR as Orion Wins FDA Nod for Tessie
08-03-2026 09:02 PM CET | Food & Beverage
Press release from: Fact.MR
ROCKVILLE, MD /August 3, 2026 – According to Fact.MR estimates, the global canine separation anxiety treatment market was valued at USD 27.7 billion in 2025. The market is projected to reach USD 29.2 billion in 2026 and is expected to grow to USD 49.4 billion by 2036, expanding at a CAGR of 5.4%. This creates an absolute dollar opportunity of USD 20.2 billion between 2026 and 2036.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=1490
Key Findings
Global market size: USD 27.7 billion (2025), USD 29.2 billion (2026), USD 49.4 billion (2036).
CAGR: 5.4% (2026-2036).
Absolute opportunity: USD 20.2 billion (2026-2036).
Behavioral Therapy Programs: 39.2% of product segment share in 2026.
Home Based Treatment: 71.3% of application segment share in 2026.
Fastest-growing countries: China (7.3% CAGR), India (6.8% CAGR).
Growth Drivers
Growing veterinary recognition of separation anxiety as a treatable clinical condition, supported by behaviorist guidance on combining medication with behavior modification, is moving more dogs into structured treatment.
Approval activity is expanding the prescription toolkit, with new active substances entering a category long limited to two FDA-approved long-term options, broadening pharmaceutical demand.
Rising pet humanization and willingness to spend on companion-animal mental health is lifting adoption of nutraceutical calming solutions and wearable calming devices alongside prescription therapy.
New active substances approved for noise aversion and separation anxiety create room for branded prescription growth and veterinary detailing.
Behavioral conditioning technology and AI-driven pet-care tools that support at-home program adherence can expand the home-based treatment segment.
Segment Analysis by Product
Behavioral Therapy Programs lead the product segment with 39.2% share in 2026. Veterinary consensus holds that medication works best paired with structured behavior modification. Trainer- and behaviorist-led programs anchor treatment, with pharmaceuticals and nutraceuticals layered according to severity. The segment is expected to retain leadership as veterinary behavior practice expands and owner-facing adherence tools mature.
Other product categories include:
Pharmaceutical Treatments (anxiolytic medications, sedative-based treatments).
Nutraceutical Solutions (calming supplements, functional pet nutrition).
Wearable Calming Devices (pressure therapy devices, electronic calming systems).
Segment Analysis by Technology
Key technologies supporting the market include:
Behavioral Conditioning Technology.
Wearable Monitoring Technology.
AI Driven Pet Care Technology.
Pharmaceutical Delivery Technology.
These enable structured behavior modification support, at-home treatment adherence tracking, and combined pharmaceutical and behavioral care. Demand concentrates in home-based settings where behavioral conditioning technology and owner-facing apps support adherence.
Segment Analysis by Application
Home Based Treatment dominates at 71.3% share in 2026. Separation anxiety manifests when owners are absent, and most behavior modification and medication administration occur at home. Remote-monitoring and adherence tools reinforce this setting. The share is likely to hold as at-home program delivery scales through digital support. Clinical veterinary treatment grows for diagnosis, prescription, and complex cases, but day-to-day management remains concentrated in the home environment.
Additional applications:
Clinical Veterinary Treatment.
Pet Training Centers.
Animal Rescue & Shelter Programs.
End-use segments cover Pet Owners, Veterinary Clinics, Dog Training Professionals, and Animal Welfare Organizations. Formulation options include Oral Pharmaceutical Formulations, Nutraceutical Formulations, Topical Formulations, and Injectable Formulations. Distribution channels include Veterinary Supply Channels, Pet Retail Channels, Online Pet Platforms, and Professional Training Networks.
Country-Level Growth Comparison
Country
CAGR (%)
Commercial Condition
China
7.3
Rapid urban dog-ownership growth and expanding companion-animal veterinary clinics in tier-1 and tier-2 cities; e-commerce platforms accelerate access to nutraceuticals and devices.
India
6.8
Veterinary clinic expansion and urban pet-care economy widen access; cost-effectiveness favors nutraceuticals and oral pharmaceuticals via organized retail and online platforms.
Germany
6.2
EU veterinary medicinal product regulation shapes authorized toolkit; high per-dog spending supports premium behavioral programs and oral formulations.
Brazil
5.7
Steady demand amid regional expansion of treated population.
U.S.
5.1
FDA approval activity broadens first-line options; mature veterinary behavior practice and high ownership sustain demand, though low insurance coverage keeps costs with owners.
UK
4.6
Steady demand under structured veterinary referral.
Japan
4.1
Mature market with high per-pet spending; growth via upgrades to branded pharmaceuticals and premium nutraceuticals; indoor-dog lifestyles sustain home-based demand.
Asia Pacific growth outpaces other regions due to rising urban dog ownership and expanding veterinary infrastructure in China and India. North America demand is supported by high companion-dog ownership, established veterinary behavior practice, and FDA-approved pharmaceuticals. Europe reflects strong pet humanization, structured referral, and EU veterinary medicine regulation.
Competitive Landscape
Leading companies include Elanco Animal Health, Virbac, Orion Corporation (Orion Animal Health), Pegasus Laboratories Inc. (PRN Pharmacal), Ceva Sante Animale, Vetoquinol, Nutramax Laboratories, and ThunderWorks (ThunderShirt).
Elanco and Virbac anchor the prescription side, holding established FDA-approved options for noise aversion and long-term separation-anxiety management plus broad veterinary distribution. Orion Corporation, through Orion Animal Health, has entered with a newly approved active substance, intensifying branded competition. Pegasus Laboratories, Nutramax, and ThunderWorks compete across nutraceutical and device formats. Boehringer Ingelheim, Ceva, and Vetoquinol participate in adjacent behavioral and calming portfolios.
Recent Developments
In May 2026, Orion Corporation received U.S. FDA approval for Tessie (tasipimidine oral solution) for dogs. The product is indicated for both noise aversion and separation anxiety, making it the first FDA-approved treatment labeled for both conditions.
In March 2025, Fetch dvm360 Conference guidance reviewed medication selection for canine separation anxiety cases. The guidance reaffirmed fluoxetine and clomipramine as FDA-approved long-term options, while noting that Sileo use in separation anxiety remains off-label.
Restraints
A narrow set of FDA-approved long-term treatments, with much prescribing off-label, constrains standardized pharmaceutical pathways and reimbursement-style support.
Low pet-insurance coverage for behavioral treatment leaves owners bearing most costs, dampening uptake of multi-month therapy programs.
Treatment requires sustained behavior modification alongside medication, and owner adherence gaps limit completion of full programs.
How to Choose: Buyer Decision Guide
Procurement and R&D teams evaluating solutions should prioritize:
Alignment with veterinary consensus that pairs structured behavior modification (39.2% product share) with pharmaceuticals rather than substituting one for the other.
Access to newly approved active substances such as tasipimidine (Tessie) that expand first-line maintenance options beyond the prior two FDA-approved long-term drugs.
Support for home-based treatment pathways (71.3% application share), including behavioral conditioning technology, AI-driven adherence tools, and remote monitoring.
Channel reach across veterinary supply, pet retail, online pet platforms, and professional training networks to convert rising pet spending into recurring revenue.
Ability to bundle pharmaceuticals, nutraceuticals, and trainer-led programs through veterinary channels to improve outcomes and program completion rates.
Formulation and delivery options (oral pharmaceutical, nutraceutical, wearable devices) matched to severity, cost sensitivity, and owner adherence constraints in target markets such as China (7.3% CAGR) and India (6.8% CAGR).
Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/report/1490/canine-separation-anxiety-treatment-market
Report Scope
The report covers global and regional market size and forecasts for 2026 to 2036 across product type, application, end use, technology, formulation, and distribution channel. It includes demand tied to companion-dog ownership growth, behavior-modification program adoption, and use of FDA-approved and off-label anxiety pharmaceuticals. Pricing analysis spans prescription pharmaceuticals, nutraceuticals, wearable devices, and professional behavior programs. Coverage includes distribution across veterinary supply, pet retail, and online pet platforms. Regions: North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa. Countries: China, India, Germany, Brazil, U.S., UK, Japan, and 30-plus others. Quantitative units: USD 29.2 billion to USD 49.4 billion at a 5.4% CAGR. Methodology combines secondary research, primary interviews (20-plus across veterinarians, behaviorists, trainers, and buyers), and demand-side modeling based on dog-population and treatment-rate data.
Explore More Related Studies Published by Fact.MR Research
Breast Cancer Diagnostics Market- https://www.factmr.com/report/55/breast-cancer-diagnostics-market
Viral Antigens Market- https://www.factmr.com/report/1305/viral-antigens-market
Vestibular Testing Systems Market- https://www.factmr.com/report/1313/vestibular-testing-market
Home Diagnostics Market- https://www.factmr.com/report/1892/home-diagnostics-market
Dental Consumables Market- https://www.factmr.com/report/4420/dental-consumables-market
Flag: The quote attributed to analyst S.N. Jha is sourced directly from published commentary on the report page and requires standard PR media sign-off before official press wire dissemination.
– Contact Us –
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com
About Fact.MR
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Canine Separation Anxiety Market Climbs from USD 27.7 billion to USD 49.4 billion by 2036 at 5.4% CAGR as Orion Wins FDA Nod for Tessie here
News-ID: 4594333 • Views: …
More Releases from Fact.MR
08-03-2026 | Food & BeverageFact.MR
Dentsply Sirona Anchors U.S. Growth as Global Dental Consumables Market Rises fr …ROCKVILLE, MD /August 3, 2026 – According to Fact.MR estimates, the global dental consumables market was valued at USD 39.4 billion in 2025. The market is projected to reach USD 42.9 billion (or USD 42.91 billion in some report sections) in 2026 and is expected to grow to USD 100.7 billion by 2036 (noted as USD 100.6 billion in the opening summary), expanding at a CAGR of 8.9%. The market…
08-03-2026 | Food & BeverageFact.MR
Abbott Laboratories Powers U.S. Home Diagnostics Advance as Market Scales from U …ROCKVILLE, MD /August 3, 2026 – The global home diagnostics market was valued at USD 7.6 billion in 2025. It is projected to reach USD 8.1 billion (also stated as USD 8.06 billion) in 2026 and USD 14.6 billion (also stated as USD 14.58 billion) by 2036, expanding at a CAGR of 6.1% and creating an absolute dollar opportunity of USD 6.52 billion between 2026 and 2036.
Glucose Monitoring is anticipated…
08-03-2026 | Food & BeverageFact.MR
Interacoustics Helps Power U.S. Vestibular Testing Systems Growth at 6.1% CAGR a …ROCKVILLE, MD /August 3, 2026 – The global vestibular testing systems market was valued at USD 960.0 million in 2025. The market is projected to reach USD 1,018.6 million in 2026 and USD 1,841.4 million by 2036, expanding at a compound annual growth rate (CAGR) of 6.1%. Absolute dollar opportunity between 2026 and 2036 is estimated at USD 822.8 million.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=1313
Key Findings
Market…
08-03-2026 | Food & BeverageFact.MR
Merck KGaA Anchors U.S. Viral Antigens Market as Global Total Climbs from USD 2. …ROCKVILLE, MD /August 3, 2026 – The global viral antigens market was valued at USD 2.9 billion in 2025. It is projected to reach USD 3.1 billion in 2026 and USD 6.1 billion by 2036, expanding at a compound annual growth rate (CAGR) of 7.0%. The market is anticipated to create an absolute dollar opportunity of USD 3.0 billion between 2026 and 2036.
Note: A Fact.MR blog post associated with the…
More Releases for USD
12-22-2025 | Health & MedicineExpert Market Research
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31MHow Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
12-22-2025 | Health & MedicineExpert Market Research
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83BHow Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient’s own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
12-22-2025 | Health & MedicineExpert Market Research
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75BHow Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population?
The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such…
12-19-2025 | Health & MedicineExpert Market Research
PACS Market USD 5.59B in 2025, USD 9.73B by 2035Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
12-19-2025 | Health & MedicineExpert Market Research
Global HEOR Market USD 1.70B-USD 6.03BHealth Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
12-16-2025 | Chemicals & MaterialsMarket Rsesearch Future
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
© 2004 – 2026 openPR. All rights reserved.
made & hosted in 
FAQ|Imprint|Privacy Policy|Terms & Conditions|Contact Point DSA|Reporting Form DSA|Cookie Settings
